Interferon Signaling Activation and LINE1 Expression under Influence of Anticancer Plant Secondary Metabolites
Authors:
- Olga VlasovaOVOlga Vlasova
- Irina AntonovaIAIrina Antonova
- Khamis MagomedovaKMKhamis Magomedova
- Alena OsipovaAOAlena Osipova
- Polina ShtompelPSPolina Shtompel
- Anna BorunovaABAnna Borunova
- Tatyana ZabotinaTZTatyana Zabotina
- Gennady BelitskyGBGennady Belitsky
- Irina BudunovaIBIrina Budunova
- Albert JordanAJAlbert Jordan
- Kirill KirsanovKKKirill Kirsanov
- Marianna YakubovskayaMYMarianna Yakubovskaya
Preprint
- 11 October 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Previously we discovered that among 15 DNA-binding plant secondary metabolites (PSMs) possessing anticancer activity, 11 compounds cause depletion of the linker histones H1.2 and/or H1.4 from chromatin fraction. Chromatin remodeling or multiH1 knocking-down is known to promote the upregulation of repetitive elements, ultimately triggering an interferon response. Herein, using HeLa cells and applying fluorescent reporter assay with flow cytometry and quantitave RT-PCR, we found that among PSMs depleting linker histones, 8 compounds significantly activate type I interferon signaling pathway. Out of these compounds resveratrol, berberine, genistein, delphinidin, naringenin and curcumin also caused LINE1 expression detected by quantitate RT-PCR and by immunefluorescent staining analysis of ORF1 LINE1 and γ-H2AX. Fisetin and quercetin, which also induced linker histone depletion, significantly activated only type I interferon signaling, but not LINE1 expression. Curcumin, sanguinarine and kaempferol, causing depletion of the linker histone H1.4 more intensively respectively to H1.2, activate interferon signaling less intensively without any changes of LINE1 expression. For 4 PSMs, which did not cause linker histone depletion, we did not observe effects of interest. Thus, we have shown for the first time that activation of type I interferon signaling accompanies chromatin remodeling caused by PSMs, and LINE1 expression often impacts this activation.Keywords
All Related Versions
This publication has 81 references indexed in Scilit:
- Kaempferol exerts a neuroprotective effect to reduce neuropathic pain throughTLR4/NF‐ĸBsignaling pathwayPhytotherapy Research, 2022
- Curcumin analogs exhibit anti-cancer activity by selectively targeting G-quadruplex forming c-myc promoter sequenceBiochimie, 2021
- Naringenin suppresses Toll‐like receptor 2‐mediated inflammatory responses through inhibition of receptor clustering on lipid raftsFood Science & Nutrition, 2020
- Antiviral activity of berberineArchives of Virology, 2020
- Genome‐wide analysis reveals alcohol dehydrogenase 1C and secreted phosphoprotein 1 for prognostic biomarkers in lung adenocarcinomaJournal of Cellular Physiology, 2019
- Sanguinarine Attenuates Lipopolysaccharide-induced Inflammation and Apoptosis by Inhibiting the TLR4/NF-κB Pathway in H9c2 CardiomyocytesCurrent Medical Science, 2018
- Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPKNaunyn-Schmiedeberg's Archives of Pharmacology, 2017
- Quercetin modulates toll-like receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic ratsMolecular and Cellular Biochemistry, 2016
- Interaction of human telomeric G-quadruplex DNA with thymoquinone: A possible mechanism for thymoquinone anticancer effectBiochimica et Biophysica Acta (BBA) - General Subjects, 2015
- Paul Ehrlich's Passion: The Origins of His Receptor ImmunologyCellular Immunology, 1999